Searched for
DCGI
Alkem Labs shares in focus as Goldman, Morgan Stanley, others purchase stake in Rs 930-crore block dealShares of Alkem Laboratories will be in focus after block deals worth around Rs 930 crore saw 17.88 lakh shares traded at Rs 5,200 apiece o...- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Weight-loss drug semaglutide set to get cheaper as generic wave builds in IndiaPrices for generic semaglutide, a popular weight-loss drug, are expected to fall by more than half in the coming months. This sharp decline...
- Drugmakers must report safety data from launch date, not approval date: CDSCOIndia's drug regulator has issued a new directive for pharmaceutical companies. Periodic Safety Update Reports for new drugs must now be su...
- Drug regulator transfers 95 officials in mass reshuffleThe Central Drugs Standard Control Organisation has moved about 95 officials across India. This reshuffle aims to improve compliance and le...
- Semaglutide API price plunges amid GLP-1 rushGlobal demand for weight-loss drugs Ozempic and Wegovy has caused semaglutide prices to drop significantly. Manufacturing has expanded rapi...
- Drug regulator halves approval timelines, eases several rulesIndia's drug regulator has significantly accelerated innovation by cutting approval timelines by over 50%. Clinical trial approvals now tak...
- Easy access to weight-loss drugs rings alarm bells among doctors, authorities; regulators step inWeight-loss drugs are being sold without prescriptions in India. This is causing alarm among doctors and authorities. People are buying the...
- Govt cracks down on GLP-1 drugs: Safety first amid weight-loss hypeIndia's government has released strict rules for GLP-1 drugs, used for diabetes and obesity. These powerful medications are now prescriptio...
- Dr. Reddy’s Lab launches India’s first DCGI-approved Semaglutide injection for Type 2 DiabetesDr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian company to rece...
- DCGI asks states to keep vigil on sale of falsified versions of 2 drugs following WHO alertsThe Drugs Controller General of India (DCGI) has issued an advisory to keep a strict watch on the sale and distribution of falsified versio...
- DCGI issues advisory as US-based Abbott recalls batches of Digene gelAbbott India Limited, through a letter dated August 18, intimated to DCGI regarding voluntary product recall of all batches of Digene Gel o...
- DCGI says medicines should be sold only under direct supervision of pharmacists in retail medical stores"Ensure that pharmacists are physically present in the retail pharmacies/medical stores, and that medicines are sold/dispensed under their ...
- Dr Reddy's gets DCGI nod for single-shot Sputnik Light vaccineThe standalone Sputnik Light vaccine is the latest jab to be approved by the DCGI as part of India's national inoculation effort against CO...
- AstraZeneca's Dapagliflozin tablets get DCGI nod for patients with chronic kidney diseaseThe company has "received Import and Market Permission in Form CT-20 (Subsequent New Drug Approval) from the DCGI for Dapagliflozin tablets...
- Glenmark Pharma shares jump nearly 9% on DCGI nod for clinical trials of Covid-19 tabletsThe company said it is the first firm in India to receive such an approval from the DCGI.
- DCGI to fast-track approval for Covid-19 drug, vaccineThe DCGI has offered seven measures for speeding up the process, from giving fast-track approval for repurposed drug to waiving animal stud...
Load More
